These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33411954)

  • 1. Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones.
    Saeed BR; Manta L; Raffel S; Pyl PT; Buss EC; Wang W; Eckstein V; Jauch A; Trumpp A; Huber W; Ho AD; Lutz C
    Int J Cancer; 2021 Jun; 148(11):2825-2838. PubMed ID: 33411954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
    Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
    Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets.
    Bruno S; Borsi E; Patuelli A; Bandini L; Mancini M; Forte D; Nanni J; Barone M; Grassi A; Cristiano G; Venturi C; Robustelli V; Atzeni G; Mosca C; De Santis S; Monaldi C; Poletti A; Terragna C; Curti A; Cavo M; Soverini S; Ottaviani E
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
    Martín I; Navarro B; Villamón E; Solano C; Serrano A; Calabuig M; Amat P; Domingo F; Abellán R; García F; Olivares MD; Chaves FJ; Tormo M; Hernández-Boluda JC
    Exp Mol Pathol; 2018 Aug; 105(1):139-143. PubMed ID: 30017658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.
    Guryanova OA; Shank K; Spitzer B; Luciani L; Koche RP; Garrett-Bakelman FE; Ganzel C; Durham BH; Mohanty A; Hoermann G; Rivera SA; Chramiec AG; Pronier E; Bastian L; Keller MD; Tovbin D; Loizou E; Weinstein AR; Gonzalez AR; Lieu YK; Rowe JM; Pastore F; McKenney AS; Krivtsov AV; Sperr WR; Cross JR; Mason CE; Tallman MS; Arcila ME; Abdel-Wahab O; Armstrong SA; Kubicek S; Staber PB; Gönen M; Paietta EM; Melnick AM; Nimer SD; Mukherjee S; Levine RL
    Nat Med; 2016 Dec; 22(12):1488-1495. PubMed ID: 27841873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse.
    Tan Y; Liu H; Chen S
    Front Med; 2015 Dec; 9(4):412-20. PubMed ID: 26482067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.
    Berenstein R; Blau IW; Suckert N; Baldus C; Pezzutto A; Dörken B; Blau O
    J Exp Clin Cancer Res; 2015 May; 34(1):55. PubMed ID: 25994761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
    Corces-Zimmerman MR; Hong WJ; Weissman IL; Medeiros BC; Majeti R
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2548-53. PubMed ID: 24550281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.
    Debarri H; Lebon D; Roumier C; Cheok M; Marceau-Renaut A; Nibourel O; Geffroy S; Helevaut N; Rousselot P; Gruson B; Gardin C; Chretien ML; Sebda S; Figeac M; Berthon C; Quesnel B; Boissel N; Castaigne S; Dombret H; Renneville A; Preudhomme C
    Oncotarget; 2015 Dec; 6(39):42345-53. PubMed ID: 26486081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Cell Type-Specific Effects of
    Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
    Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl.
    Göhring G; Thomay K; Schmidt G; Ripperger T; Xu M; Wittner N; Chao MM; Baumann I; Niewisch M; Reinhardt D; Klingebiel T; Thol F; Schlegelberger B; Niemeyer CM
    Leuk Lymphoma; 2017 Mar; 58(3):718-721. PubMed ID: 27892742
    [No Abstract]   [Full Text] [Related]  

  • 14. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
    Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
    PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of IDH mutations in AML during morphologic remission.
    Ramanan R; Tiong IS; Ivey A; Ong DM; Brown FC; Chua C; Das T; Curtis DJ
    Leuk Res; 2023 Jan; 124():106993. PubMed ID: 36459762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients.
    Mechaal A; Menif S; Abbes S; Safra I
    Adv Med Sci; 2019 Sep; 64(2):395-401. PubMed ID: 31331874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
    Christen F; Hoyer K; Yoshida K; Hou HA; Waldhueter N; Heuser M; Hills RK; Chan W; Hablesreiter R; Blau O; Ochi Y; Klement P; Chou WC; Blau IW; Tang JL; Zemojtel T; Shiraishi Y; Shiozawa Y; Thol F; Ganser A; Löwenberg B; Linch DC; Bullinger L; Valk PJM; Tien HF; Gale RE; Ogawa S; Damm F
    Blood; 2019 Mar; 133(10):1140-1151. PubMed ID: 30610028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.
    Tan Y; Liu Z; Wang W; Zhu G; Guo J; Chen X; Zheng C; Xu Z; Chang J; Ren F; Wang H
    Leuk Res; 2018 Jun; 69():89-93. PubMed ID: 29705537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients.
    Greif PA; Hartmann L; Vosberg S; Stief SM; Mattes R; Hellmann I; Metzeler KH; Herold T; Bamopoulos SA; Kerbs P; Jurinovic V; Schumacher D; Pastore F; Bräundl K; Zellmeier E; Ksienzyk B; Konstandin NP; Schneider S; Graf A; Krebs S; Blum H; Neumann M; Baldus CD; Bohlander SK; Wolf S; Görlich D; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2018 Apr; 24(7):1716-1726. PubMed ID: 29330206
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic profiling and directed ex vivo drug analysis of an unclassifiable myelodysplastic/myeloproliferative neoplasm progressing into acute myeloid leukemia.
    Hyrenius-Wittsten A; Sturesson H; Bidgoli M; Jonson T; Ehinger M; Lilljebjörn H; Scheding S; Andersson AK
    Genes Chromosomes Cancer; 2016 Nov; 55(11):847-54. PubMed ID: 27240832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.